This is a StreetInsider.com Premium Only Page

Adamis Pharmaceuticals (ADMP) – Hot FDA News

Sep 21, 2022 07:30 AM Adamis Pharmaceuticals (ADMP) Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects Did Not Achieve its Primary Endpoint

Mar 21, 2022 04:06 PM Adamis Pharmaceuticals (ADMP) Issues Nationwide Voluntary Recall of SYMJEPI Injection for Potential Manufacturing Defect

Oct 18, 2021 07:30 AM

Jun 3, 2021 02:08 PM

Feb 22, 2021 09:07 AM

Nov 16, 2020 06:45 AM

Nov 25, 2019 08:01 AM

Sep 27, 2018 04:22 PM

Jun 15, 2017 02:32 PM

Jun 6, 2016 06:46 AM

Mar 30, 2015 06:27 AM